Enantioenriched butenolide and furanone synthesis platform for natural product production

Technology
Conceptual
University

A versatile chemistry-driven methodology providing straightforward, highly enantioselective access to chiral butenolides and furanones, including several natural products. The platform demonstrates broad substrate scope and delivers a series of highly enantioenriched compounds suitable for pharmaceutical, agrochemical, and fragrance research applications.

Overview

This solution offers a powerful synthetic methodology for producing highly enantioenriched butenolides and furanones, including several natural products. Developed through a chemistry-driven approach, the method showcases exceptional versatility in accessing chiral butenolides with high enantioselectivity. Butenolides are five-membered lactone ring structures that serve as key building blocks in many biologically active molecules, making them valuable across pharmaceutical, agrochemical, and specialty chemical industries.

The technology addresses a significant challenge in synthetic chemistry: the efficient production of chiral furanone derivatives with precise stereochemical control. By providing a streamlined route to these important structural motifs, the methodology reduces synthesis complexity while maintaining high enantiopurity, offering researchers and industry partners access to compounds that are otherwise difficult to obtain.

Technical specifications

Key features:

  • Highly enantioselective methodology delivering chiral butenolides with excellent stereochemical control
  • Broad substrate scope enabling synthesis of a wide variety of furanone derivatives
  • Direct access to several natural products through the same synthetic route
  • Chemistry-driven approach that demonstrates the versatility of the core methodology
  • Streamlined synthesis reducing the number of steps compared to traditional routes
  • Applicable to multiple compound classes within the butenolide/furanone family

The method centers on a key reaction developed in the research group that serves as the pivotal transformation enabling access to the target molecular architectures. This approach allows for the preparation of diverse structures from a common synthetic platform.

Technology readiness level

The compounds have been successfully synthesized using the developed methodology, demonstrating proof-of-concept across multiple target structures including natural products. The chemistry has been validated through the preparation of a series of highly enantioenriched furanones, confirming the reliability and reproducibility of the approach. Further optimization and scale-up studies would be valuable next steps for partners interested in commercial-scale production or specific application development.


About Queen Mary University of London

Queen Mary University of London is a comprehensive public research university within the University of London, serving a large and diverse community across campuses in East and Central London. Integration with a major NHS hospital network provides co‑located clinical and translational facilities and access to trial infrastructure and real‑world datasets. An on‑site innovation ecosystem with wet‑lab and startup space, plus proximity to the City and Tech City, connects researchers to London’s finance and digital industry clusters. Research is supported by competitive funding from UK Research and Innovation councils, the National Institute for Health and Care Research, and leading UK charities. A dedicated technology transfer company manages IP, licensing, consultancy, spinouts, and Knowledge Transfer Partnerships to streamline collaboration.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.